Clinical Trial Update: Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor [Phase 3]

View source ↗

Summary

This completed Phase 3 trial evaluated adjuvant imatinib mesylate versus observation after surgical resection for localized gastrointestinal stromal tumor to as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Drugs mentioned

• Imatinib mesylate (Imatinib)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Gastrointestinal Stromal Tumor | Phase 3 | Status: COMPLETED